Archive — US — techcrunch
OpenAI invests in Sam Altman’s brain computer interface startup Merge Labs
OpenAI has invested in Merge Labs, a brain-computer interface startup led by CEO Sam Altman. Merge Labs aims to develop non-invasive technologies to connect with neurons using molecules rather than electrodes, potentially enhancing human capabilities alongside AI. This investment is part of a $250 million seed round at an $850 million valuation, intensifying Altman and Elon Musk's competition in the BCI space.
Key points
- OpenAI invests in Merge Labs, which focuses on non-invasive brain-computer interfaces.
- Merge Labs raised $250 million in seed funding at an $850 million valuation, with OpenAI as the largest investor.
- The technology aims to interface with neurons using molecules, promising to restore abilities and enhance human-AI connections.
- OpenAI's investment underscores increased competition with Elon Musk's Neuralink, which currently uses invasive methods.
- The partnership will involve collaboration on scientific models to accelerate advancements in neuroscience and bioengineering.
Why it matters
- This move aligns with 2025 IT trends emphasizing the integration of AI with biological systems.
- The BCI sector is rapidly developing, following advancements in AI and neurotechnology.
- Sam Altman's vision of human-AI merging reflects broader discussions within the tech industry about the implications of advanced AI.
The investment in Merge Labs signifies a critical step towards non-invasive BCIs, reflecting both OpenAI's forward-thinking approach and the competitive landscape in neurotechnology, setting the stage for future developments in human-AI interaction.